Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 3/20 | 0.49 |
| ▸ | TYR | P14679 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359337 | 0.89 | DAO (0.52) | DAOELANETYRPOLBGAA | |
| SCHEMBL20543223 | 0.86 | PPARG (0.59) | DAOELANETYRPOLBGAA | |
| SCHEMBL361245 | 0.83 | DAO (0.58) | DAOELANETYR | |
| SCHEMBL20543148 | 0.81 | DAO (0.55) | DAOELANETYRPOLBGAA | |
| SCHEMBL20543161 | 0.80 | DAO (0.54) | DAOELANETYRPOLBGAA | |
| SCHEMBL7550581 | 0.79 | POLB (0.60) | DAOELANETYRPOLBGAA | |
| SCHEMBL9085769 | 0.78 | SERPINE1 (0.56) | DAOELANETYR | |
| SCHEMBL7558334 | 0.77 | POLB (0.63) | DAOELANETYRPOLBGAA | |
| SCHEMBL360885 | 0.77 | POLB (0.57) | DAOELANETYRPOLBGAA | |
| SCHEMBL3220810 | 0.77 | DAO (0.63) | DAOELANETYRPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180370940-A1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | AMOREPACIFIC CORPORATION (KR) | 2018-12-27 | — | — | US | claimed |
| EP-3395807-A1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | Amorepacific Corporation (KR) | 2018-10-31 | — | — | EP | claimed |
| EP-3395807-B1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | AMOREPACIFIC CORP (KR) | 2020-10-14 | — | — | EP | disclosed |
| EP-3395807-B1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | AMOREPACIFIC CORP (KR) | 2020-10-14 | — | — | EP | disclosed |
| US-20180370940-A1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | AMOREPACIFIC CORPORATION (KR) | 2018-12-27 | — | — | US | disclosed |
| EP-3395807-A1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | Amorepacific Corporation (KR) | 2018-10-31 | — | — | EP | disclosed |
| CN-108473458-A | Bigcatkin willow acid derivative compound, preparation method and the skin-lightening cosmetic constituent comprising the compound | 爱茉莉太平洋股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180370940-A1 | SALICYLIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION FOR WHITENING COMPRISING SAME | TYR, DDC, KMO | DAO 10/4885NPC1 4498/4885RAB9A 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.